NasdaqCM - Delayed Quote USD

XORTX Therapeutics Inc. (XRTX)

2.9300 +0.3400 (+13.13%)
At close: April 26 at 4:00 PM EDT
2.8600 -0.07 (-2.39%)
After hours: April 26 at 7:35 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
7,293.8359
9,862.2539
2,862.3261
1,019.8744
Operating Income
-7,293.8359
-9,862.2539
-2,862.3261
-1,019.8744
Net Non Operating Interest Income Expense
255.2218
101.3668
-4.3905
-10.5963
Other Income Expense
332.1433
2,772.0063
1,570.8295
23.0661
Pretax Income
-6,706.4708
-6,988.8808
-1,295.8871
-1,007.4046
Net Income Common Stockholders
-6,706.4708
-6,988.8808
-1,295.8871
-1,007.4046
Diluted NI Available to Com Stockholders
-6,706.4708
-6,988.8808
-1,295.8871
-1,007.4046
Basic EPS
-3.60
-4.71
-1.20
-1.34
Diluted EPS
-3.60
-4.71
-1.20
-1.34
Basic Average Shares
1,879.4620
1,479.9130
1,094.1820
740.4470
Diluted Average Shares
1,879.4620
1,479.9130
1,094.1820
740.4470
Total Expenses
7,293.8359
9,862.2539
2,862.3261
1,019.8744
Net Income from Continuing & Discontinued Operation
-6,706.4708
-6,988.8808
-1,295.8871
-1,007.4046
Normalized Income
-7,038.6141
-9,760.8871
-2,866.7166
-1,030.4707
Interest Income
255.2218
101.3668
--
--
Interest Expense
--
--
4.3905
10.5963
Net Interest Income
255.2218
101.3668
-4.3905
-10.5963
EBIT
-4,420.4628
-6,988.8808
-1,291.4966
-996.8082
EBITDA
-4,285.2595
-6,933.4225
-1,277.4717
-980.7797
Reconciled Depreciation
135.2033
55.4583
14.0249
16.0286
Net Income from Continuing Operation Net Minority Interest
-6,706.4708
-6,988.8808
-1,295.8871
-1,007.4046
Total Unusual Items Excluding Goodwill
332.1433
2,772.0063
1,570.8295
23.0661
Total Unusual Items
332.1433
2,772.0063
1,570.8295
23.0661
Normalized EBITDA
-4,617.4028
-9,705.4288
-2,848.3012
-1,003.8458
12/31/2020 - 9/23/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers